The present disclosure relates to a composition for treating or preventing alopecia including decursin, wherein when administered externally or orally, the decursin promotes secretion of KGF in hair follicle tissues, prevents apoptosis of hair follicle cells, and exhibits the effect of promoting hair growth, thereby being useful for the treatment or prevention of alopecia.

The present invention relates to the use of a compound of formula (I): in which R1, R2 and R3 independently denote: —a group of formula (II), or —a hydrogen atom H, it being understood that at least one of the radicals R1, R2, R3 denotes a group of formula (II); and also the salts thereof, the solvates thereof, and/or the isomers thereof, for preventing and/or cosmetically treating the signs of skin aging. ##STR00001##

A shampoo composition having from about 0.025% to about 0.25% histidine, by weight of the shampoo composition; from about 2% to about 50% of one or more detersive surfactants, by weight of the shampoo composition; and a gel matrix having from about 0.1% to about 20% of one or more fatty alcohols, by weight of the gel matrix; from about 0.1% to about 10% of one or more gel matrix surfactants, by weight of the gel matrix; and from about 20% to about 95% of an aqueous carrier, by weight of the gel matrix.

A method of strengthening the skin barrier by application of a composition comprising at least one mRNA biomarker and/ or mRNA biomarker group enhancement compound in which the mRNA biomarker/mRNA biomarker group is involved in comified envelope formation.

Topically administrable lyzate of dedifferentiated cells of the plant Helichrysum stoechas for improving the moisturizing of the skin and/or the scalp and/or the lips.

A clear cleansing composition directed to from about 3 wt % to about 35 wt % of an anionic surfactant; from about 5 wt % to about 15% of an amphoteric surfactant; from about 0.01 wt % to about 2 wt % of a cationic polymer; from about 0 wt % to about 1.0 wt % of inorganic salts; from about 0.01% to about 10% of a hydroxamic acid or hydroxamic acid derivative; an aqueous carrier, wherein the composition is substantially free of sulfate based surfactant and wherein the composition has a % T value of greater than about 70.

This TRPA1 activity inhibitor contains a compound represented by formula (I) wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each independently represent a hydrogen atom or a methyl group, and R.sup.5, R.sup.6, R.sup.7 and R.sup.8 each independently represent a hydrogen atom, a methyl group or —O—R.sup.9—OH (in the formula, R.sup.9 represents an alkylene group optionally having a substituent group), provided that at least one group of R.sup.5, R.sup.6, R.sup.7 and R.sup.8 is —O—R.sup.9—OH. ##STR00001##

This TRPA1 activity inhibitor contains a compound represented by formula (I) wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each independently represent a hydrogen atom or a methyl group, and R.sup.5, R.sup.6, R.sup.7 and R.sup.8 each independently represent a hydrogen atom, a methyl group or —O—R.sup.9—OH (in the formula, R.sup.9 represents an alkylene group optionally having a substituent group), provided that at least one group of R.sup.5, R.sup.6, R.sup.7 and R.sup.8 is —O—R.sup.9—OH. ##STR00001##

A cosmetic composition including component (A), which is an aqueous gelling agent represented by general formula (1) described in the specification, and a component (B), which is a polymeric thickening agent, wherein the component (A) presents a viscosity of an aqueous solution containing 1 mass % of at 25° C. of 1,000 to 5,000 mPa.Math.s and a clouding point of the aqueous solution containing 1 mass % of component (A) of 60° C. to 80° C., and has a weight average molecular weight of 10,000 to 30,000; a method for producing the aqueous gelling agent and a method for producing the cosmetic composition are provided.

Disclosed is a composition comprising at least one core-shell microcapsule in a suspending medium. The microcapsule comprises a core and a shell around said core. The shell comprises a hyperbranched polysaccharide selected from the group consisting of amylopectins, dextrins, hyperbranched starches, glycogen and phytoglycogen and mixtures thereof.